| Effect | None |
| Trial Design | Cohort |
| Trial Length | 6+ Months |
| Number of Subjects | 3365 |
| Sex | Both Genders |
In a followup study where garlic was used for 7.3 years and failed to reduce precancerous lesions of the stomach, 7.3 years later participants were noted to have a nonsignificant reduction in stomach cancer and esophageal cancer and mortality risk associated with garlic therapy.
